The Experimental Imaging Sciences Committee of the ECOG-ACRIN Cancer Research Group is the key entry point for studies of new imaging agents. It develops and conducts trials for early evaluation of new imaging agents and approaches, and plans for their broader application. At least one representative from each disease-oriented committee or working group in the Therapeutic Studies Program is a member. This committee seeks leaders in imaging, regardless of their institution’s membership status in the Group.
David A. Mankoff, MD, PhD
University of Pennsylvania and the Abramson Cancer Center
Anthony F. Shields MD, PhD
Wayne State University and the Barbara Ann Karmanos Cancer Center
|Cancer Control and Outcomes Program|
|Therapeutic Studies Program|
|Biomarker Sciences Program|